Perspectives on current approaches to virtual screening in drug discovery

I Muegge, J Bentzien, Y Ge - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction For the past two decades, virtual screening (VS) has been an efficient hit finding
approach for drug discovery. Today, billions of commercially accessible compounds are …

Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity

MG Salem, SAA El-Ata, EH Elsayed, SN Mali… - RSC …, 2023 - pubs.rsc.org
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …

Deep generative models in the quest for anticancer drugs: ways forward

V Romanelli, C Cerchia, A Lavecchia - Frontiers in Drug Discovery, 2024 - frontiersin.org
Drug discovery is a costly and time-consuming process, especially because of the significant
expenses connected with the high percentage of clinical trial failures. As such, there is a …

A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3

J Wei, Y Pan, Z Shen, L Shen, L Xu, W Yu… - Frontiers in …, 2023 - frontiersin.org
The JAKs protein family is composed of four isoforms, and JAK3 has been regarded as a
druggable target for the development of drugs to treat various diseases, including …

Molecular docking study of frequently used food additives for selected targets depending on the chromosomal abnormalities they cause

F Okus, D Yuzbasioglu, F Unal - Toxicology, 2024 - Elsevier
Food additives (FAs)(flavor enhancers, sweeteners, etc.) protect foods during storage and
transportation, making them attractive to consumers. Today, while the desire to access …